skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: autor: Zetterberg, Henrik remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline

Lista, Simone ; Molinuevo, Jose L ; Cavedo, Enrica ; Rami, Lorena ; Amouyel, Philippe ; Teipel, Stefan J ; Garaci, Francesco ; Toschi, Nicola ; Habert, Marie-Odile ; Blennow, Kaj ; Zetterberg, Henrik ; O'Bryant, Sid E ; Johnson, Leigh ; Galluzzi, Samantha ; Bokde, Arun L W ; Broich, Karl ; Herholz, Karl ; Bakardjian, Hovagim ; Dubois, Bruno ; Jessen, Frank ; Carrillo, Maria C ; Aisen, Paul S ; Hampel, Harald Butler, Christopher ; Wilcock, Gordon ; Tales, Andrea ; Phillips, Judith ; Jessen, Frank ; Bayer, Tony

Journal of Alzheimer's disease, 2015-09, Vol.48 Suppl 1 (s1), p.S171-S191 [Periódico revisado por pares]

Netherlands

Texto completo disponível

Citações Citado por
2
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorderse .(Research / Original Investigation)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorderse .(Research / Original Investigation)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorderse .(Research / Original Investigation)

Strandberg, Olof ; Smith, Ruben ; Leuzy, Antoine ; Lopera, Francisco ; Proctor, Nicholas K ; Chen, Yinghua ; Blennow, Kaj ; Beach, Thomas G ; Palmqvist, Sebastian ; Chai, Xiyun ; Dage, Jeffrey L ; Hansson, Oskar ; Villegas, Andres ; Quiroz, Yakeel T ; Zetterberg, Henrik ; Stomrud, Erik ; Mattsson-Carlgren, Niklas ; Janelidze, Shorena ; Serrano, Geidy E ; Sepulveda-Falla, Diego ; Reiman, Eric M

JAMA : the journal of the American Medical Association, 2020-08, Vol.324 (8), p.772 [Periódico revisado por pares]

American Medical Association

Texto completo disponível

Citações Citado por
3
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

Llorens Torres, Franc ; Hermann, Peter ; Villar Piqué, Anna ; Diaz Lucena, Daniela ; Nägga, Katarina ; Hansson, Oskar ; Santana, Isabel ; Schmitz, Matthias ; Schmidt, Christian ; Varges, Daniela ; Goebel, Stefan ; Dumurgier, Julien ; Zetterberg, Henrik ; Blennow, Kaj ; Paquet, Claire ; Baldeiras, Inês ; Ferrer, Isidro (Ferrer Abizanda) ; Zerr, Inga

Nature Publishing Group 2020-01

Texto completo disponível

Citações Citado por
4
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
Material Type:
Artigo 		Adicionar ao Meu Espaço

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020

Hampel, Harald ; Lista, Simone ; Teipel, Stefan J. ; Garaci, Francesco ; Nisticò, Robert ; Blennow, Kaj ; Zetterberg, Henrik ; Bertram, Lars ; Duyckaerts, Charles ; Bakardjian, Hovagim ; Drzezga, Alexander ; Colliot, Olivier ; Epelbaum, Stéphane ; Broich, Karl ; Lehéricy, Stéphane ; Brice, Alexis ; Khachaturian, Zaven S. ; Aisen, Paul S. ; Dubois, Bruno

Biochemical pharmacology, 2014-04, Vol.88 (4), p.426-449 [Periódico revisado por pares]

England: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Material Type:
Artigo 		Adicionar ao Meu Espaço

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

Hampel, Harald ; O'Bryant, Sid E ; Molinuevo, José L ; Zetterberg, Henrik ; Masters, Colin L ; Lista, Simone ; Kiddle, Steven J ; Batrla, Richard ; Blennow, Kaj

Nature reviews. Neurology, 2018-11, Vol.14 (11), p.639-652 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies
Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies

Zetterberg, Henrik ; Bendlin, Barbara B

Molecular psychiatry, 2021-01, Vol.26 (1), p.296-308 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia

Janelidze, Shorena ; Mattsson, Niklas ; Palmqvist, Sebastian ; Smith, Ruben ; Beach, Thomas G ; Serrano, Geidy E ; Chai, Xiyun ; Proctor, Nicholas K ; Eichenlaub, Udo ; Zetterberg, Henrik ; Blennow, Kaj ; Reiman, Eric M ; Stomrud, Erik ; Dage, Jeffrey L ; Hansson, Oskar

Nature medicine, 2020-03, Vol.26 (3), p.379-386 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults

Idland, Ane Victoria ; Sala Llonch, Roser ; Watne, Leiv Otto ; Braekhus, Anne ; Hansson, Oskar ; Blennow, Kaj ; Zetterberg, Henrik ; Sørensen, Øystein ; Walhovd, Kristine Beate ; Wyller, Torgeir Bruun ; Fjell, Anders Martin

Elsevier B.V 2020-04

Texto completo disponível

Citações Citado por
9
Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
Material Type:
Artigo 		Adicionar ao Meu Espaço

Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures

Falgàs, Neus ; Ruiz‐Peris, Mariona ; Pérez‐Millan, Agnès ; Sala‐Llonch, Roser ; Antonell, Anna ; Balasa, Mircea ; Borrego‐Écija, Sergi ; Ramos‐Campoy, Oscar ; Augé, Josep Maria ; Castellví, Magdalena ; Tort‐Merino, Adrià ; Olives, Jaume ; Fernández‐Villullas, Guadalupe ; Blennow, Kaj ; Zetterberg, Henrik ; Bargalló, Núria ; Lladó, Albert ; Sánchez‐Valle, Raquel

Human brain mapping, 2020-06, Vol.41 (8), p.2004-2013 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
10
Advantages and disadvantages of the use of the CSF Amyloid [beta] 42/40 ratio in the diagnosis of Alzheimer's Disease
Advantages and disadvantages of the use of the CSF Amyloid [beta] 42/40 ratio in the diagnosis of Alzheimer's Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Advantages and disadvantages of the use of the CSF Amyloid [beta] 42/40 ratio in the diagnosis of Alzheimer's Disease

Hansson, Oskar ; Lehmann, Sylvain ; Otto, Markus ; Zetterberg, Henrik ; Lewczuk, Piotr

Alzheimer's research & therapy, 2019-04, Vol.11 (1) [Periódico revisado por pares]

BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (319)
  2. Revistas revisadas por pares (307)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (349)
  2. Book Chapters  (2)
  3. Livros  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2006  (7)
  2. 2006Até2009  (31)
  3. 2010Até2013  (70)
  4. 2014Até2018  (78)
  5. Após 2018  (167)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (349)
  2. Japonês  (42)
  3. Sueco  (3)
  4. Norueguês  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.